Skip to main navigation Skip to main content Skip to page footer

PARASKEVAS GEORGE

GEORGE PARASKEVAS, MD, PhD.

Associate Professor of Neurology, Cognitive and Movement Disorders Unit and Unit of Neurochemistry and Biological Markers, 1st Department of Neurology, School of Medicine, National and Kapodistrian University of Athens.

 

Education - training

  • 1982-1989: National and Kapodistrian University of Athens, School of Medicine.
  • Specialization: Resident of Neurology, National and Kapodistrian University of Athens, Eginition Hospital, Athens. Specialty Neurology, with Lisence to practice the Specialty of Neurology, Athens 22/9/95
  • Thesis: 7/7/95 – 12/7/95 “Levels of serotonin and antioxidant substances (vitamins C and E, glutathione) in plasma and CSF and their correlation in Parkinson’s Disease”. Doctor in Medicine, School of Medicine of the National and Kapodistrian University of Athens. Degree-excellent 1/3/2000.

 

Clinial / Laboratory work

  • Member of the Cognitive and Movement Disorders Unit of the 1st Department of Neurology, National and Kapodistrian University of Athens: Clinical and neuropsychological study of patients with dementia and movement disorders, validation of neuropsychological tests and use of them in differential diagnosis and in follow up (including effects of treatment), correlation of the various neuropsychological profiles with CSF biomarkers. Additional interest in hereditary brain small vessel disorders including CADASIL, COL4A1/A2 and CARASIL.
  • Actively engaged in the research wok of the Unit of Neurochemistry and Biological Markers. Since 1997, the major laboratory activity has been the application of ELISA methods for the quantitative analysis of CSF total tau (T-tau), phosphorylated tau (phospho-T) and beta-amyloid peptide (Aβ42), which are of particular importance for the diagnosis of Alzheimer's disease and other dementias. Intensive work for the JPND-BIOMARKAPD project.

 

Research, publications and editorial work

Research mainly focused on neurodegenerative disorders and especially dementing disorders such as Alzheimer’s disease, dementia with Lewy bodies, vascular dementia, frontotemporal dementia, but also movement disorders including Parkinson’s disease. Research is both clinical and laboratory, especially in the fields of neuropsychology and neurochemistry of CSF biomarkers (tau, phospho-tau and Aβ42):

  • 1 Doctoral Thesis
  • 1 Chapter in an International Book
  • 1 National Book (in Greek), 2 chapters in National books and editing of 2 translations
  • More than 100 publications in international journals
  • More than 94 presentations in international meetings,
  • 24 Publications in National journals (in Greek)
  • 3 full-length papers in National conference proceedings (in Greek)
  • 80 presentations in national meetings (in Greek)
  • More than 47 invited lectures in scientific meetings and round tables
  • More than 2300 citations